Merck & Co., Inc. (VIE:MRK)

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of EUR 243.38 billion. The enterprise value is 263.04 billion.

Market Cap	243.38B
Enterprise Value	263.04B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Dec 15, 2025

Share Statistics

Current Share Class	2.48B
Shares Outstanding	n/a
Shares Change (YoY)	-1.34%
Shares Change (QoQ)	-0.40%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	78.92%
Float	2.48B

Valuation Ratios

The trailing PE ratio is 15.65 and the forward PE ratio is 22.38.

PE Ratio	15.65
Forward PE	22.38
PS Ratio	4.40
PB Ratio	5.51
P/TBV Ratio	19.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	16.92
EV / Sales	4.78
EV / EBITDA	10.79
EV / EBIT	12.68
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.80
Debt / EBITDA	1.44
Debt / FCF	n/a
Interest Coverage	18.06

Financial Efficiency

Return on equity (ROE) is 37.17% and return on invested capital (ROIC) is 28.30%.

Return on Equity (ROE)	37.17%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	28.30%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	5.50%
Revenue Per Employee	748,241
Profits Per Employee	210,094
Employee Count	75,000
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Merck & Co. has paid 2.39 billion in taxes.

Income Tax	2.39B
Effective Tax Rate	13.31%

Stock Price Statistics

The stock price has increased by +2.51% in the last 52 weeks. The beta is 0.30, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	+2.51%
50-Day Moving Average	89.63
200-Day Moving Average	75.77
Relative Strength Index (RSI)	68.96
Average Volume (20 Days)	117

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.37

Income Statement

In the last 12 months, Merck & Co. had revenue of EUR 55.37 billion and earned 15.55 billion in profits. Earnings per share was 6.20.

Revenue	55.37B
Gross Profit	42.68B
Operating Income	20.87B
Pretax Income	17.94B
Net Income	15.55B
EBITDA	24.53B
EBIT	20.87B
Earnings Per Share (EPS)	6.20

Balance Sheet

The company has 15.51 billion in cash and 35.24 billion in debt, with a net cash position of -19.73 billion.

Cash & Cash Equivalents	15.51B
Total Debt	35.24B
Net Cash	-19.73B
Net Cash Per Share	n/a
Equity (Book Value)	44.21B
Book Value Per Share	17.75
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 77.08%, with operating and profit margins of 37.69% and 28.08%.

Gross Margin	77.08%
Operating Margin	37.69%
Pretax Margin	32.41%
Profit Margin	28.08%
EBITDA Margin	44.30%
EBIT Margin	37.69%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 2.86, which amounts to a dividend yield of 3.02%.

Dividend Per Share	2.86
Dividend Yield	3.02%
Dividend Growth (YoY)	-1.00%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.34%
Shareholder Yield	4.36%
Earnings Yield	6.39%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1